Related Experiment Video

Updated: Mar 20, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.6K

A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced Senescence

Mariana Acevedo1, Mathieu Vernier1, Lian Mignacca1

  • 1Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec, Canada.

Cancer Research
|May 22, 2016
PubMed

Insights

Promyelocytic leukemia (PML) normally suppresses tumors by inducing senescence. However, cancer cells resist this. This study found that CDK4/6 kinases block PML-induced senescence, and inhibiting them restores this tumor suppression.

Area of Science:

  • Oncology
  • Cellular Biology
  • Epigenetics

Background:

  • Promyelocytic leukemia (PML) is a tumor suppressor that induces cellular senescence.
  • Tumor cells often resist PML-induced senescence, hindering its therapeutic potential.

Purpose of the Study:

  • To investigate the mechanisms by which tumor cells resist PML-induced senescence.
  • To identify potential therapeutic strategies to overcome this resistance.

Main Methods:

  • Investigated the role of cyclin-dependent kinases (CDKs) CDK4 and CDK6 in senescence resistance.
  • Utilized RNA interference and pharmacological inhibition of CDKs.
  • Assessed senescence induction, tumor cell proliferation, autophagy, gene expression, and DNA methylation.
  • Examined the interaction between CDK4 and DNA methyltransferase DNMT1.

Main Results:

  • CDK4/6 activation was essential and sufficient to block PML-induced senescence.
  • Inhibiting CDK4/6 restored senescence and reduced tumor potential in xenograft models.
  • Senescence induction correlated with increased autophagy, repressed E2F targets, and blocked DNA methylation.
  • DNA methylation inhibitors reversed resistance; CDK inhibition promoted DNMT1 degradation via autophagy.
  • CDK4 directly phosphorylated and stabilized DNMT1.

Conclusions:

  • CDK4/6 activity is a key mechanism of resistance to PML-induced senescence.
  • CDK4/6 inhibitors can overcome this resistance by modulating epigenetic pathways.
  • CDK4/6 inhibitors may serve as epigenetic modulators to enhance senescence-based cancer therapies.

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.8K
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

13.3K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K